Home / Nervous system / Levetiracetam
ATC N03AX14 · Antiepileptics
Levetiracetam shortage
As of 31 Oct 2026, Levetiracetam has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Austria), covering 44 products.
Countries4/5
Products44packs or presentations
Short since30 May 20233.4 years ago
Earliest return13 Nov 2026company estimate
No return date15products
Main reasonManufacturing problem
Timeline
GermanyItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | LEVETIRACETAM BASICS 250 mg Filmtabletten | Basics GmbH | 1 Jan 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | LEVETIRACETAM BASICS 250 mg Filmtabletten | Basics GmbH | 1 Jan 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | LEVETIRACETAM BASICS 250 mg Filmtabletten | Basics GmbH | 1 Jan 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Levetiracetam Holsten 250 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 4 Jul 2025 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Levetiracetam Holsten 250 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 4 Jul 2025 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Levetiracetam Holsten 250 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 4 Jul 2025 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | LEVETIRACETAM BASICS 1000 mg Filmtabletten | Basics GmbH | 2 Dec 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | LEVETIRACETAM BASICS 1000 mg Filmtabletten | Basics GmbH | 2 Dec 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Levetiracetam Holsten 500 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 5 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Levetiracetam Holsten 500 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 5 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Levetiracetam Holsten 750 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 5 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Levetiracetam Holsten 750 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 5 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Levetiracetam Holsten 750 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 5 Jan 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | LEVETIRACETAM BASICS 750 mg Filmtabletten | Basics GmbH | 2 Apr 2026 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Levetiracetam-Hormosan 100 mg/ml Lösung zum Einnehmen | Hormosan Pharma Gesellschaft mit beschränkter Haftung | 1 May 2026 | 16 Nov 2026 | Increased demand Erhöhte Nachfrage |
| DE | Levetiracetam HEXAL 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung | H e x a l Aktiengesellschaft | 6 Jul 2026 | 13 Nov 2026 | Other Sonstige |
| DE | LEVETIRACETAM BASICS 500 mg Filmtabletten | Basics GmbH | 14 Jul 2026 | 31 Dec 2026 | Manufacturing problem Produktionsproblem |
| DE | LEVETIRACETAM BASICS 500 mg Filmtabletten | Basics GmbH | 14 Jul 2026 | 31 Dec 2026 | Manufacturing problem Produktionsproblem |
| DE | Levetiracetam Holsten 1000 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 10 Aug 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Levetiracetam Holsten 1000 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 10 Aug 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| IT | LEVETIRACETAM ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 May 2023 | not given | Increased demand Elevata richiesta |
| IT | LEVETIRACETAM ZENTIVA | ZENTIVA ITALIA S.R.L. | 12 Jun 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | LEVETIRACETAM ACCORD HEALTHCARE | ACCORD HEALTHCARE, S.L.U. | 10 Dec 2025 | not given | Increased demand Elevata richiesta |
| IT | MATEVER | PHARMATHEN S.A. | 20 Jan 2026 | 31 Dec 2026 | Increased demand Elevata richiesta/problemi produttivi: forniture discontinue |
| IT | LEVETIRACETAM TEVA ITALIA | TEVA ITALIA S.R.L. | 16 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LEVETIRACETAM ACCORD HEALTHCARE | ACCORD HEALTHCARE, S.L.U. | 27 Feb 2026 | not given | Increased demand Elevata richiesta |
| IT | LEVETIRACETAM MYLAN GENERICS | MYLAN S.P.A. | 5 May 2026 | not given | Increased demand Elevata richiesta |
| IT | LEVETIRACETAM ACCORD | ACCORD HEALTHCARE, S.L.U. | 22 May 2026 | not given | Increased demand Elevata richiesta |
| IT | LEVETIRACETAM EG STADA ITALIA | EG S.P.A. | 29 May 2026 | not given | Increased demand Elevata richiesta |
| IT | LEVETIRACETAM AUROBINDO ITALIA | Eugia Pharma (Malta) Limited | 1 Jun 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LEVETIRACETAM EG STADA ITALIA | EG S.P.A. | 29 Jul 2026 | not given | Increased demand Elevata richiesta |
| IT | LEVETIRACETAM MYLAN | MYLAN S.P.A. | 10 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LEVETIRACETAM TEVA | TEVA B.V. | 21 Aug 2026 | 30 Nov 2026 | Increased demand Elevata richiesta (carenza relativa solo al canale retail) |
| IT | LEVETIRACETAM ALMUS | ALMUS S.R.L. | 21 Sep 2026 | 31 Dec 2026 | Increased demand Elevata richiesta/problemi produttivi |
| IT | LEVETIRACETAM TILLOMED | TILLOMED ITALIA SRL | 26 Oct 2026 | 30 Nov 2026 | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | LEVETIRACETAM HOSPIRA announced | PFIZER EUROPE MA EEIG | 2 Nov 2026 | 28 Feb 2027 | Manufacturing problem Problemi produttivi |
| IT | LEVETIRACETAM ALMUS announced | ALMUS S.R.L. | 6 Nov 2026 | 28 Feb 2027 | Manufacturing problem Problemi produttivi |
| IT | LEVETIRACETAM ACCORD announced | ACCORD HEALTHCARE, S.L.U. | 27 Nov 2026 | not given | Increased demand Elevata richiesta |
| IT | LEVETIRACETAM PENSA announced | TOWA PHARMACEUTICAL S.P.A. | 1 Dec 2026 | 30 Jun 2027 | Manufacturing problem Problemi produttivi |
| ES | LEVETIRACETAM AUROVITAS 100 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 10 viales de 5 ml | Eugia Pharma (Malta) Limited | 13 Jul 2026 | 14 Dec 2026 | Not stated |
| ES | TIRBAS 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 100 comprimidos | Laboratorios Alter S.A. | 9 Aug 2026 | not given | Not stated |
| ES | LEVETIRACETAM KERN PHARMA 100 MG/ML CONCENTRADO SOLUCION PARA PERFUSION EFG , 10 viales de 5 ml | Kern Pharma S.L. | 21 Oct 2026 | not given | Not stated |
| AT | Levetiracetam Krka 1000 mg Filmtabletten, 30 Stück | KRKA d.d. Novo Mesto | 26 Aug 2026 | 15 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Levetiracetam Sandoz 500 mg - Filmtabletten, 100 Stück | Sandoz GmbH | 23 Oct 2026 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.